American Journal of Epidemiology Advance Access published online on April 18, 2007
American Journal of Epidemiology, doi:10.1093/aje/kwm065
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contribution |
Fetal Growth and Acute Childhood Leukemia: Looking Beyond Birth Weight
From the Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia
Correspondence to Dr. Elizabeth Milne, Telethon Institute for Child Health Research, P.O. Box 855, Perth 6872, Western Australia (e-mail: lizm{at}ichr.uwa.edu.au).
Received for publication November 9, 2006. Accepted for publication January 22, 2007.
The authors examined the relation between birth weight, intrauterine growth, and risk of childhood leukemia using population-based linked health data from Western Australia. A cohort of 576,593 infants born in 1980–2004 were followed from birth to diagnosis of acute lymphoblastic leukemia (ALL) (n = 243) or acute myeloid leukemia (AML) (n = 36) before their 15th birthday, death, or the end of follow-up (December 31, 2005). Data were analyzed using Cox regression. Risk of ALL was positively associated with the proportion of optimal birth weight—a measure of the appropriateness of fetal growth—particularly among children younger than 5 years; the hazard ratio for a 1-standard-deviation increase in proportion of optimal birth weight was 1.25 (95% confidence interval: 1.07, 1.47). Among children younger than 5 years not classified as having high birth weight (defined as >3,500 g, >3,800 g, and >4,000 g), a 1-unit increase in proportion of optimal birth weight was associated with an approximately 40% increase in ALL risk. This suggests that accelerated growth, rather than high birth weight per se, is involved in the etiology of ALL. These findings are consistent with a role for insulin-like growth factor I in the causal pathway. Findings for AML were inconclusive, probably because of small numbers.
birth weight; fetal development; leukemia; medical record linkage; proportional hazards models; risk factors
Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CI, confidence interval; IGF-I, insulin-like growth factor I
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Milne, J. A. Royle, N. H. de Klerk, E. Blair, H. Bailey, C. Cole, J. Attia, R. J. Scott, and B. K. Armstrong Fetal Growth and Risk of Childhood Acute Lymphoblastic Leukemia: Results From an Australian Case-Control Study Am. J. Epidemiol., July 15, 2009; 170(2): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Chokkalingam and P. A. Buffler Genetic susceptibility to childhood leukaemia Radiat Prot Dosimetry, December 1, 2008; 132(2): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. de Klerk and E. Milne Overview of recent studies on childhood leukaemia, intra-uterine growth and diet Radiat Prot Dosimetry, December 1, 2008; 132(2): 255 - 258. [Abstract] [Full Text] [PDF]
|
|